E-cigarettes: smoking cessation aid or a dangerous habit?

A recent study with adult smokers who had approached the NHS Stop Smoking Services compared e-cigarettes with nicotine-replacement therapy (NRT) as part of a smoking cessation service.

After a year, 18% of e-cigarette users had stopped smoking tobacco compared with 9.9% of NRT users. However, 80% of people using e-cigarettes in the trial continued to use them 12 months on, while the preferred results would be for them to be smoke and e-cigarette free.

Experts estimate that vaping is at least 95% less harmful than smoking cigarettes, but recent reports of deaths and lung disease in the US linked to vaping have caused a worldwide alarm about the use of e-cigarettes.

In October we asked the M3 Community:

"Should e-cigarettes be considered a smoking cessation aid or a dangerous habit?"

The survey has been conducted amongst 8004 M3 members in Europe (United Kingdom, Italy, Germany, Spain and France). Overall in Europe 63% of the participants, think vaping is a dangerous habit.

The majority in the United Kingdom have the same opinion, with 64% thinking of e-cigarettes as containing health risks and 36% as smoking cessation aid. Respondents in Italy and Germany share the same opinion, with 65% and 70% thinking that vaping is a dangerous habit.
In Spain, the results are even higher with 82% of the respondents not convinced of vaping being helpful for smoking purposes while France is the only country in which the majority of respondents think of it as a tool to help smokers.

Click on the pictures below to see the results from every country and compare your opinion with the M3 Global Research community.

By registering with M3 Global Research you will receive the Monthly Pulse directly to your inbox and you will be able to share your opinion about relevant healthcare related issue and compare your thoughts with your colleagues around the World.


Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.